TY - JOUR
T1 - Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency
AU - University of Washington Center for Mendelian Genomics
AU - Simon, Mariella T.
AU - Ng, Bobby G.
AU - Friederich, Marisa W.
AU - Wang, Raymond Y.
AU - Boyer, Monica
AU - Kircher, Martin
AU - Collard, Renata
AU - Buckingham, Kati J.
AU - Chang, Richard
AU - Shendure, Jay
AU - Nickerson, Deborah A.
AU - Bamshad, Michael J.
AU - Van Hove, Johan L.K.
AU - Freeze, Hudson H.
AU - Abdenur, Jose E.
N1 - Publisher Copyright:
© 2017 Elsevier B.V. and Mitochondria Research Society
PY - 2017/5/1
Y1 - 2017/5/1
N2 - We report the clinical, biochemical, and molecular findings in two brothers with encephalopathy and multi-systemic disease. Abnormal transferrin glycoforms were suggestive of a type I congenital disorder of glycosylation (CDG). While exome sequencing was negative for CDG related candidate genes, the testing revealed compound heterozygous mutations in the mitochondrial elongation factor G gene (GFM1). One of the mutations had been reported previously while the second, novel variant was found deep in intron 6, activating a cryptic splice site. Functional studies demonstrated decreased GFM1 protein levels, suggested disrupted assembly of mitochondrial complexes III and V and decreased activities of mitochondrial complexes I and IV, all indicating combined OXPHOS deficiency.
AB - We report the clinical, biochemical, and molecular findings in two brothers with encephalopathy and multi-systemic disease. Abnormal transferrin glycoforms were suggestive of a type I congenital disorder of glycosylation (CDG). While exome sequencing was negative for CDG related candidate genes, the testing revealed compound heterozygous mutations in the mitochondrial elongation factor G gene (GFM1). One of the mutations had been reported previously while the second, novel variant was found deep in intron 6, activating a cryptic splice site. Functional studies demonstrated decreased GFM1 protein levels, suggested disrupted assembly of mitochondrial complexes III and V and decreased activities of mitochondrial complexes I and IV, all indicating combined OXPHOS deficiency.
UR - http://www.scopus.com/inward/record.url?scp=85014058920&partnerID=8YFLogxK
U2 - 10.1016/j.mito.2017.02.004
DO - 10.1016/j.mito.2017.02.004
M3 - Journal articles
C2 - 28216230
AN - SCOPUS:85014058920
SN - 1567-7249
VL - 34
SP - 84
EP - 90
JO - Mitochondrion
JF - Mitochondrion
ER -